Cellectar Biosciences cellectarbiosciences.com

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar's products' unique mechanism of action is based on selective accumulation and retention in malignant tumors and not normal cells.

Cellectar Therapeutics, formerly Novelos Therapeutics, is a radiopharmaceuticals company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar's novel product candidates combine lipid-like molecule...Show all

See All Exits Recent Exits

Phone: 617-244-1616

Fax:

One Gateway Center
Suite 504
Newton, 02458
Massachusetts, United States

Cellectar Biosciences - Investments & Acquisitions

Show Real Data Cellectar Biosciences Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-04-12CellectarAcquired
See all 1 investments